促销时间表 FSD Pharma Inc.
先进的时间表
简单图表
关于公司 FSD Pharma Inc.
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.| IPO date | 2018-06-08 |
|---|---|
| ISIN | CA35954B2066 |
| Industry | IT Services |
| Sector | Information Technology |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.fsdpharma.com |
| Цена ао | 0.701 |
| 每日价格变化: | 0% (5.39) |
|---|---|
| 每周价格变化: | 0% (5.39) |
| 每月价格变化: | 0% (5.39) |
| 3个月内价格变化: | +40% (3.85) |
| 六个月内的价格变化: | -43.59% (9.555) |
| 每年价格变化: | +485.87% (0.92) |
| 3年内价格变化: | +428.43% (1.02) |
| 5年内价格变化: | +4.46% (5.16) |
| 10年价格变化: | 0% (5.39) |
| 年初以来价格变化: | 0% (5.39) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| AdvisorShares Investments, LLC | 270316 | 0.67 |
| Renaissance Technologies, LLC | 69200 | 0.17 |
| Scotia Capital Inc. | 61273 | 0.15 |
| UBS Group AG | 26362 | 0.07 |
| Group One Trading, L.P. | 17653 | 0.04 |
| TWO SIGMA SECURITIES, LLC | 13584 | 0.03 |
| Susquehanna International Group, LLP | 11791 | 0.03 |
| Td Waterhouse Canada Inc. | 10373 | 0.03 |
| Citadel Advisors Llc | 2483 | 0.01 |
| Royal Bank of Canada | 2450 | 0.01 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| SPDR Portfolio Emerging Markets ETF | 0.00339 | 11.59 | 3.1879 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.00291 | 15.96 | 3.34087 |
| SPDR Portfolio Europe ETF | 0.00138 | 8.94 | 3.66537 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Zeeshan Saeed | Founder, CEO, President & Executive Co-Chairman | 222.62k | 1970 (55 年) |
| Mr. Anthony John Durkacz | Founder & Executive Co-Chairman | 222.62k | 1976 (49 年) |
| Mr. Nathan Coyle CPA | Chief Financial Officer | 178.21k | 1981 (44 年) |
| Mr. Donal Carroll CPA | Chief Operating Officer | 225.62k | 1977 (48 年) |
| Dr. Lakshmi P. Kotra BPHARM, Ph.D. | CEO of Lucid & Director | 144.72k | 1971 (54 年) |
| Dr. Andrzej Chruscinski M.D., Ph.D. | Vice President of Clinical & Scientific Affairs of Lucid | 110.3k | |
| Mr. Kevin Cassidy | Vice President of Quality-Lucid | 144.82k | |
| Ms. Maryann Adesso | Corporate Secretary | N/A | |
| Randell Mack | President of FSD BioSciences | N/A |
地址: Canada, Toronto. ON ML A, 199 Bay Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.fsdpharma.com
网站: https://www.fsdpharma.com
